Zepbound Savings Card: Who Gets $25, Who Pays $499

Lilly's Zepbound savings card gets you Zepbound for as little as $25 for a 28-day fill, but only if you have commercial insurance that already covers it, and the card pays at most $100 a month and $1,300 a year. If your commercial plan does not cover Zepbound, the same card sets the single-dose pen at $499 a fill. If you are on Medicare, Medicaid, TRICARE, the VA or any other government plan, you cannot use the card at all. For most people paying cash, the $299–$449 KwikPen self-pay price is lower than the $499 tier. Every 2026 version of the card expires on December 31, 2026¹.

We read Lilly's savings page and its full terms on October 5, 2026. The quotes below come from those terms. For the cross-brand picture, see do GLP-1 savings cards actually lower the price?. For the KwikPen dose ladder in detail, see Zepbound cost without insurance.

The three prices in one table

The "Zepbound savings card" is really several programs under one name, and which one you get depends on your insurance.

Scenario 1: your commercial plan covers Zepbound

This is the scenario behind the "$25" headline. The terms read: "You must have commercial drug insurance that covers Zepbound single-dose pen and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill."

The limit is in the next sentence: "Card savings are subject to a maximum monthly savings of up to $100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription fill and a separate maximum annual savings of up to $1,300 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year."

So $25 is a floor, not a promise. The card takes up to $100 off your copay, and you pay the rest:

• Plan copay of $75: the card pays $50 and you pay $25.
• Plan copay of $125: the card pays $100 and you pay $25.
• Plan copay of $200: the card pays $100 and you pay $100.

The deductible matters even more. Before you meet it, your share of a covered fill can be hundreds of dollars, and the card still takes off only $100. Lilly defines a month as "28-days and up to 4 single-dose pens," so 13 fills fit in a year. Thirteen fills at $100 off each comes to exactly the $1,300 annual cap. The cap usually starts to bite only if you fill more often or Lilly changes the terms.

Scenario 2: you have commercial insurance, but it doesn't cover Zepbound

This is where the $499 comes from. If your plan excludes weight-loss drugs, the card terms let you "pay as low as $499 for your 1-month prescription fill of Zepbound single-dose pen," again defined as 28 days and up to 4 pens, for up to 13 fills a year.

At $499 every 28 days, the single-dose pen costs $6,487 a year. That is still cheaper than the list price, but it is usually not your cheapest brand-name option. With the same plan you can use the KwikPen card instead: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg and above. That is cheaper than $499 at every dose, as long as you keep to the refill window.

The KwikPen is a multi-dose pen, and Lilly notes that "pen needles are required and sold separately." If your prescriber wrote the script for the single-dose pen, the KwikPen price only applies once they rewrite it for the KwikPen. Ask before you pay $499 a month out of habit.

Scenario 3: you're on Medicare, Medicaid, TRICARE or VA

The savings card is closed to you. The eligibility clause requires that "You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program." If you join one of these programs mid-year, you lose eligibility. Lilly asks you to call the program when that happens.

You still have two other routes:

• Medicare Part D: the GLP-1 Bridge. From July 1, 2026 through December 31, 2027, eligible Part D enrollees can get Zepbound for a $50 copay when it is prescribed for weight management. Only the KwikPen qualifies. CMS says the single-dose vial and single-dose pen are not available through the Bridge². Eligibility follows CMS's clinical criteria, and the $50 does not count toward your Part D out-of-pocket total. Our Medicare GLP-1 Bridge explainer covers who qualifies.
• Cash self-pay. On its Medicare and government-insurance tabs, Lilly's page shows the same KwikPen or vial self-pay offer "starting at $299." The self-pay card terms make it cash-only: you agree you "will not seek or accept reimbursement for any out-of-pocket costs ... from any third-party payer, including private insurance or state or federal healthcare programs."

Medicaid coverage of weight-loss drugs depends on your state. Check your state's preferred drug list before you pay cash.

Worked example: a year at the 10 mg maintenance dose

Here is the same patient, a 10 mg maintenance dose and 13 fills a year, under each route. All brand prices are Lilly's published terms as of October 2026.

The KwikPen row is a range for a reason. The self-pay card "may be used for a maximum of up to 11 prescription fills per calendar year," but 13 28-day fills fit in a year. Lilly's terms do not say what fills 12 and 13 cost. At worst they cost the $699 regular price, which is how $5,837 becomes $6,337.

The traps in the fine print

The 45-day refill rule. The $449 price at 7.5 mg and above holds only if "you complete your refill purchase ... within 45 days of the delivery/received date of your previous" fill. Refill later and the regular price applies: $499 at 7.5 mg and $699 at 10–15 mg.

Savings may not apply at the register. The terms warn that "savings may not be applied at the point of sale and may require further action from you." If that happens you file a reimbursement claim, and Lilly's deadline for claims is March 31, 2027.

HSA and FSA money. The covered-patient card bars you from seeking reimbursement "from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card." The self-pay card goes further: you agree not to seek reimbursement for your out-of-pocket costs from "any insurance plan, healthcare reimbursement account, or other third-party payer." Read that clause before you plan to pay with pre-tax dollars. Our HSA and FSA explainer covers the IRS side.

Alternate funding programs. If your employer plan uses an "alternate funding program" that makes coverage depend on manufacturer assistance, the terms say you "are not eligible for and are prohibited from using" the card.

It's single-dose pen and KwikPen only. The card lists specific NDCs, and "other methods of administration are not eligible for Program savings." It also "cannot be combined" with any other discount card or coupon, so you can't stack a pharmacy discount card on top.

Mounjaro is not a substitute here. It is the same molecule, but it is approved for type 2 diabetes, and this card's terms cover Zepbound only. We explain why the prices differ in Mounjaro vs Zepbound.

How to activate it

Lilly requires activation ("Card activation is required"), and both insured cards also require "a valid patient HIPAA authorization." You sign up through Lilly's Zepbound savings page, choose the tab that matches your insurance, and show the card at LillyDirect or another pharmacy. You must "meet the Card eligibility criteria, terms and conditions every time you use the Card." If your coverage changes, the card you qualify for changes too.

After December 31, 2026

Every Zepbound card version we read says "Card expires and savings end on 12/31/2026." Lilly also reserves the right to change caps "with or without notice at any time for any reason." The terms we read on October 5, 2026 cover 2026 only, so don't count on January pricing until Lilly publishes new terms.

The compounded alternative, priced honestly

Across the 368 programs we track that publish a tirzepatide price (counted October 2026), the median is $249 a month. Of those, 52 publish a flat, month-to-month rate with no plan term attached, and the cheapest of these is $129 a month. The full sorted list is in our cheapest tirzepatide ranking.

That beats any non-covered Zepbound route on price. It is not the same product, though. Zepbound is an FDA-approved finished medicine³. Compounded tirzepatide is not FDA-approved, and the FDA does not review it for safety, effectiveness or quality before it is sold⁴. If you want brand Zepbound through a telehealth prescriber, Sesame Care and Found both list it. If you are comparing compounded programs, CoreAge Rx, a featured partner, is one of the programs on the ranking.

Which route to check first

1. 1Commercial insurance: ask your plan whether it covers the Zepbound single-dose pen, and what your copay or deductible is. If it is covered, the card usually wins.
2. 2Commercial plan that excludes it, or no insurance: compare the KwikPen self-pay price at your maintenance dose with the $499 pen tier. The KwikPen is cheaper at every dose if you refill on time.
3. 3Medicare Part D: check Bridge eligibility before you pay anything in cash.
4. 4Still too expensive: price a verified compounded program, knowing the trade-off.